Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin C

This article was originally published in The Tan Sheet

Executive Summary

RDA for women should be increased to 90 mg based on new depletion-repletion study data, NIH researchers say in Aug. 14 Proceedings of the National Academy of Sciences. Mark Levine, MD, National Institute of Diabetes & Digestive & Kidney Diseases, et al., note current RDA of 75 mg was based on extrapolated data for men. Levine and colleagues evaluated long-term intake in 15 women who received doses ranging from 30 mg-2,500 mg daily, finding a "steep sigmoidal relationship between vitamin C doses and resulting [plasma] concentrations for doses of 30 mg-100 mg daily." Current RDA "is on the steep linear portion" of the curve, "where small dose changes cause large changes in plasma concentration," Levine et al. say. They also suggest current 90 mg RDA for men may be too low

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092944

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel